BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 16505315)

  • 21. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.
    Link H; Huang YM
    J Neuroimmunol; 2006 Nov; 180(1-2):17-28. PubMed ID: 16945427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Optic neuritis, brain stem syndromes and myelitis: rapid conversion to multiple sclerosis].
    Tintoré M; Rovira A; Hernández D; Río J; Marzo ME; Montalban X
    Med Clin (Barc); 1999 May; 112(18):693-4. PubMed ID: 10374200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis according to baseline MRI findings: comparison of revised McDonald criteria and Swanton modified criteria.
    Lo CP; Kao HW; Chen SY; Hsueh CJ; Lin WC; Hsu WL; Wu DK; Liu GC
    J Neurol Neurosurg Psychiatry; 2009 Oct; 80(10):1107-9. PubMed ID: 19546108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The type of involvement of the nervous system in multiple sclerosis in children and adolescents].
    Gergont A; Nowak A; Piotrowska A; Kaciński M
    Przegl Lek; 2008; 65(11):789-94. PubMed ID: 19205362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early relapse risk after a first CNS inflammatory demyelination episode: examining international consensus definitions.
    Dale RC; Pillai SC
    Dev Med Child Neurol; 2007 Dec; 49(12):887-93. PubMed ID: 18039234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of intramuscular interferon beta-1a in patients with clinically isolated syndrome: analysis of subgroups based on new risk criteria.
    O'Connor P; Kinkel RP; Kremenchutzky M
    Mult Scler; 2009 Jun; 15(6):728-34. PubMed ID: 19482863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cerebral and spinal MRI examination in patients with clinically isolated syndrome and definite multiple sclerosis].
    Sailer M; Fazekas F; Gass A; Kappos L; Radue EW; Rieckmann P; Toyka K; Wiendl H; Bendszus M
    Rofo; 2008 Nov; 180(11):994-1001. PubMed ID: 18937154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRI in the diagnosis of pediatric multiple sclerosis.
    Callen DJ; Shroff MM; Branson HM; Lotze T; Li DK; Stephens D; Banwell BL
    Neurology; 2009 Mar; 72(11):961-7. PubMed ID: 19038852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of cigarette smoking on conversion from clinically isolated syndrome to clinically definite multiple sclerosis.
    Arikanoglu A; Shugaiv E; Tüzün E; Eraksoy M
    Int J Neurosci; 2013 Jul; 123(7):476-9. PubMed ID: 23302010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of early interferon beta-1a therapy on conversion to multiple sclerosis in Iranian patients with a first demyelinating event.
    Pakdaman H; Sahraian MA; Fallah A; Pakdaman R; Ghareghozli K; Ghafarpour M; Rahimian E; Shirani A
    Acta Neurol Scand; 2007 Jun; 115(6):429-31. PubMed ID: 17511854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The development of multiple sclerosis following an isolated episode of optic neuritis. Magnetic resonance study].
    Río J; Nos C; Rovira A; Tintoré M; Codina A; Montalbán X
    Med Clin (Barc); 1997 Sep; 109(10):370-2. PubMed ID: 9379718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive factors for multiple sclerosis in patients with clinically isolated spinal cord syndrome.
    Ruet A; Deloire MS; Ouallet JC; Molinier S; Brochet B
    Mult Scler; 2011 Mar; 17(3):312-8. PubMed ID: 21071465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Course of illness and prognosis of multiple sclerosis. 2: Predictive value of clinical and paraclinical factors].
    Flachenecker P; Hartung HP
    Nervenarzt; 1996 Jun; 67(6):444-51. PubMed ID: 8767198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal fluid oligoclonal IgM bands predict early conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome.
    Ferraro D; Simone AM; Bedin R; Galli V; Vitetta F; Federzoni L; D'Amico R; Merelli E; Nichelli PF; Sola P
    J Neuroimmunol; 2013 Apr; 257(1-2):76-81. PubMed ID: 23434160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinically isolated syndromes: predicting and delaying multiple sclerosis.
    Thrower BW
    Neurology; 2007 Jun; 68(24 Suppl 4):S12-5. PubMed ID: 17562845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of the 2010 revised criteria for the diagnosis of multiple sclerosis to patients with clinically isolated syndromes.
    Runia TF; Jafari N; Hintzen RQ
    Eur J Neurol; 2013 Dec; 20(12):1510-6. PubMed ID: 23906114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical, magnetic resonance imaging, cerebrospinal fluid and electrophysiological characteristics of the earliest multiple sclerosis.
    Rot U; Ledinek AH; Jazbec SS
    Clin Neurol Neurosurg; 2008 Mar; 110(3):233-8. PubMed ID: 18093725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on clinically isolated syndrome.
    Thouvenot É
    Presse Med; 2015 Apr; 44(4 Pt 2):e121-36. PubMed ID: 25813099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis.
    Sbardella E; Tomassini V; Stromillo ML; Filippini N; Battaglini M; Ruggieri S; Ausili Cefaro L; Raz E; Gasperini C; Sormani MP; Pantano P; Pozzilli C; De Stefano N
    Mult Scler; 2011 Dec; 17(12):1432-40. PubMed ID: 21729978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [IGG index or oligoclonal bands in the diagnosis of disseminated sclerosis].
    Sellebjerg F; Frederiksen JL
    Ugeskr Laeger; 1993 Feb; 155(8):558-60. PubMed ID: 8451791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.